Use of Bacillus Calmette-Guérin as adjuvant in human cell vaccines.
D000276:Adjuvants, Immunologic; D000328:Adult; D000917:Antibody Formation; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed; D007111:Immunity, Cellular; D005779:Immunodiffusion; D007136:Immunoglobulins / Q000032:analysis; D007167:Immunotherapy; D007951:Leukemia, Myeloid / Q000628:therapy*; D008228:Lymphoma, Non-Hodgkin / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009163:Mycobacterium bovis; D012516:Osteosarcoma / Q000276:immunology
D000276:Adjuvants, Immunologic; D007136:Immunoglobulins